drug repurposed offer expedite economy rout develop new clinic therapeutic comparison trait develop growthbas highthroughput screen concomit enable rapid identify therapeutic use investing drug howe method combat microorgan norm growth pattern staphylococcu aureus smallcoloni variant sv subpopul auxotroph key compound biosynthet pathway result low rate format also assoc reduce antibiotic suspect sv bail revert normal cell state thought contribute recur infect thu critic need identify antimicrobial agent potent order effect treat chronic accordingly describe adapt deny kind abbas death report assay member food administer fdaapprov library display bactericid active four daunorubicin ketoconazol rifapentin sitafloxacin exhibit stable investing show methicillinsuscept resist well within establish biofilm taken together result demons use ak screen smallmolecul library highlight potent repurposed ndor state import convent antibiotic fail success osteomyel endocard devicerel airway recur emerge recalcitr studi therapy scvrelat little success emphasis novel discovery costly timeconsum process alter strategy could wellcharacter offlabel until treat studi adapt suggest avenue admit paradigm easily drugchem 